| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 28.81▼ | 28.81▼ | 28.81▼ | 29.07▼ | 30.38▼ |
| MA10 | 28.90▼ | 28.90▼ | 28.90▼ | 29.83▼ | 29.88▼ |
| MA20 | 29.00▼ | 28.96▼ | 28.99▼ | 30.57▼ | 28.61▲ |
| MA50 | 29.39▼ | 29.87▼ | 29.89▼ | 30.03▼ | N/A |
| MA100 | 30.00▼ | 30.34▼ | 30.72▼ | 28.65▲ | N/A |
| MA200 | 30.79▼ | 30.84▼ | 30.28▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.015▲ | 0.018▲ | -0.315▼ | N/A |
| RSI | 34.084▼ | 34.238▼ | 33.885▼ | 34.488▼ | 53.664▲ |
| STOCH | 12.879▼ | 9.770▼ | 8.138▼ | 15.988▼ | 57.935 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -89.011▼ | -61.347 |
| CCI | -173.729▼ | -163.237▼ | -166.237▼ | -119.522▼ | -7.598 |
|
Monday, May 18, 2020 01:05 AM
SOUTH SAN FRANCISCO, Calif., May 18, 2020 /PRNewswire/ -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for anxiety and ...
|
|
Tuesday, April 21, 2020 07:15 AM
Westport, CT, April 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that on April 16, 2020 its subsidiary ViralClear Pharmaceuticals, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/06/26 | 28.92 | 29.00 | 28.65 | 28.72 | 70,452 |
| 11/06/26 | 29.04 | 29.255 | 28.86 | 28.93 | 20,475 |
| 10/06/26 | 29.03 | 29.3703 | 28.93 | 28.98 | 25,616 |
| 09/06/26 | 29.52 | 29.52 | 28.42 | 29.12 | 51,235 |
| 08/06/26 | 29.87 | 30.005 | 29.59 | 29.59 | 38,682 |
| 05/06/26 | 30.24 | 30.38 | 29.26 | 29.31 | 72,294 |
| 04/06/26 | 30.31 | 30.77 | 30.26 | 30.65 | 152,561 |
| 03/06/26 | 31.125 | 31.15 | 30.91 | 31.00 | 57,324 |
| 02/06/26 | 31.01 | 31.10 | 30.69 | 31.10 | 57,672 |
| 01/06/26 | 30.43 | 31.135 | 30.42 | 30.8897 | 78,039 |
|
|
||||
|
|
||||
|
|